Salzburg Therapeutics' Incubator/Accelerator Round

Salzburg Therapeutics raised a round of funding on , . Investors include Babcock Demon Incubator.

Salzburg Therapeutics is a drug development company that is developing Cytotoxamer and Genotoxamer products for cancer treatment. The company's technology aims to provide a solution for delivering act…

Articles about Salzburg Therapeutics' Incubator/Accelerator Round: